Needham & Company Upgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Hold

November 6, 2013 6:48 AM EST Send to a Friend
Needham & Company upgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Underperform to Hold.

Analyst Elliot Wilbur comments, "Our ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login